Effective January 3, 2022, the Board of Directors of Kiniksa Pharmaceuticals, Ltd. appointed Eben Tessari as the Company's SVP, Chief Operating Officer and principal operating officer. Mr. Tessari, 40, served as the Company's SVP, Chief Business Officer from March 2018 until January 2022. Prior to that, he served as the Company's SVP, Business Development from July 2015 until March 2018.

In these roles, Mr. Tessari oversaw the Company's business development efforts, including the expansion of its product candidate portfolio.